Sanofi on track to deliver flu vaccine
pharmafile | September 30, 2009 | News story | Sales and Marketing |Â Â Sanofi, h1n1Â
French company Sanofi-Pasteur is on track to deliver its H1N1 flu vaccine over the next two months, chief executive Chris Viehbacher told Le Figaro newspaper.
He said the first doses of its vaccine would be delivered to the US by mid-October, and he hoped the vaccine would also be available in France by the end of November.
Sanofi, which has the largest vaccine manufacturing capacity of all the companies making H1N1 vaccines, could in theory make 800 million doses of its H1N1 flu vaccine per year.
However, unlike GSK and Novartis, Sanofi does not have adjuvant technology, which boosts the potency of antigen, meaning the same volume of vaccine can be split into more doses.
a2a_linkname=”Pharmafocus”;a2a_linkurl=”http://www.pharmafocus.com”;a2a_num_services=6;a2a_prioritize=[”twitter”,”linkedin”,”facebook”,”delicious”,”friendfeed”,”stumbleupon”,”reddit”];
Related Content

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria
Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition
The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline
Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology …






